Omnicell Stock Analysis

OMCL Stock  USD 27.87  0.41  1.49%   
Omnicell is undervalued with Real Value of 32.77 and Target Price of 38.5. The main objective of Omnicell stock analysis is to determine its intrinsic value, which is an estimate of what Omnicell is worth, separate from its market price. There are two main types of Omnicell's stock analysis: fundamental analysis and technical analysis.
The Omnicell stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

Omnicell Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell has Price/Earnings To Growth (PEG) ratio of 2.28. The entity had not issued any dividends in recent years. Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California. Omnicell operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 4000 people. To find out more about Omnicell contact Randall Lipps at 877 415 9990 or learn more at https://www.omnicell.com.

Omnicell Quarterly Total Revenue

269.67 Million

Omnicell Investment Alerts

Omnicell generated a negative expected return over the last 90 days
Omnicell has high historical volatility and very poor performance
Omnicell has a strong financial position based on the latest SEC filings
Over 98.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Balyasny Asset Management L.P. Has 3.01 Million Position in Omnicell, Inc.

Omnicell Upcoming and Recent Events

8th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Omnicell Largest EPS Surprises

Earnings surprises can significantly impact Omnicell's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2011-05-02
2011-03-310.10.110.0110 
2010-10-27
2010-09-300.10.110.0110 
2010-04-26
2010-03-310.10.09-0.0110 
View All Earnings Estimates

Omnicell Environmental, Social, and Governance (ESG) Scores

Omnicell's ESG score is a quantitative measure that evaluates Omnicell's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Omnicell's operations that may have significant financial implications and affect Omnicell's stock price as well as guide investors towards more socially responsible investments.

Omnicell Thematic Classifications

In addition to having Omnicell stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Computers Idea
Computers
USA Equities from Computers industry as classified by Fama & French

Omnicell Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
D. E. Shaw & Co Lp2024-12-31
940.6 K
Morgan Stanley - Brokerage Accounts2024-12-31
873.5 K
Federated Hermes Inc2025-03-31
746.5 K
Royal Bank Of Canada2024-12-31
712.2 K
Bank Of New York Mellon Corp2024-12-31
639.8 K
Mirae Asset Global Etfs Holdings Ltd.2024-12-31
639.5 K
Charles Schwab Investment Management Inc2024-12-31
616.2 K
Northern Trust Corp2024-12-31
565 K
Millennium Management Llc2024-12-31
499.8 K
Blackrock Inc2024-12-31
8.2 M
Vanguard Group Inc2024-12-31
5.6 M
Note, although Omnicell's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Omnicell Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.29 B.

Omnicell Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.01  0.02 
Return On Assets 0.01  0.01 
Return On Equity 0.01  0.01 

Management Efficiency

At this time, Omnicell's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.01 this year, although the value of Return On Capital Employed will most likely fall to 0.0002. At this time, Omnicell's Intangible Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Intangibles To Total Assets will most likely fall to 0.23. Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 27.00  28.35 
Tangible Book Value Per Share 5.69  5.97 
Enterprise Value Over EBITDA 22.90  22.05 
Price Book Value Ratio 1.65  1.57 
Enterprise Value Multiple 22.90  22.05 
Price Fair Value 1.65  1.57 
Enterprise Value1.9 B1.7 B
Omnicell showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Operating Margin
(0.04)
Profit Margin
0.0187
Beta
0.779
Return On Assets
0.0037
Return On Equity
0.0173

Technical Drivers

As of the 13th of May 2025, Omnicell holds the Coefficient Of Variation of (647.90), variance of 10.25, and Risk Adjusted Performance of (0.26). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omnicell, as well as the relationship between them. Please check Omnicell information ratio and potential upside to decide if Omnicell is priced some-what accurately, providing market reflects its current price of 27.87 per share. Given that Omnicell has information ratio of (0.13), we recommend you to check out Omnicell's recent market performance to make sure the company can sustain itself at a future point.

Omnicell Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Omnicell price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Omnicell Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omnicell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omnicell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omnicell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Omnicell Outstanding Bonds

Omnicell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omnicell uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omnicell bonds can be classified according to their maturity, which is the date when Omnicell has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Omnicell Predictive Daily Indicators

Omnicell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Omnicell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Omnicell Corporate Filings

10Q
7th of May 2025
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
6th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
28th of April 2025
Other Reports
ViewVerify
3rd of April 2025
Other Reports
ViewVerify
F4
18th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
12th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
11th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
4th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Omnicell Forecast Models

Omnicell's time-series forecasting models are one of many Omnicell's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omnicell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Omnicell Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Omnicell prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Omnicell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Omnicell. By using and applying Omnicell Stock analysis, traders can create a robust methodology for identifying Omnicell entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.02  0.02 
Net Profit Margin 0.01  0.02 
Gross Profit Margin 0.42  0.57 

Current Omnicell Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Omnicell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Omnicell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
38.5Buy7Odds
Omnicell current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Omnicell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Omnicell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Omnicell, talking to its executives and customers, or listening to Omnicell conference calls.
Omnicell Analyst Advice Details

Omnicell Stock Analysis Indicators

Omnicell stock analysis indicators help investors evaluate how Omnicell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Omnicell shares will generate the highest return on investment. By understating and applying Omnicell stock analysis, traders can identify Omnicell position entry and exit signals to maximize returns.
Begin Period Cash Flow501 M
Long Term Debt166.4 M
Common Stock Shares Outstanding46.3 M
Total Stockholder Equity1.2 B
Tax Provision13.1 M
Quarterly Earnings Growth Y O Y0.558
Property Plant And Equipment Net138.3 M
Cash And Short Term Investments381.7 M
Cash369.2 M
Accounts Payable51.8 M
Net Debt13.3 M
50 Day M A33.2144
Total Current Liabilities595.7 M
Other Operating Expenses1.1 B
Non Current Assets Total1.3 B
Forward Price Earnings29.4985
Non Currrent Assets Other75.5 M
Stock Based Compensation39.3 M
When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.558
Earnings Share
0.46
Revenue Per Share
24.55
Quarterly Revenue Growth
0.096
Return On Assets
0.0037
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.